Home
Morten Lund-Johansen's picture

Morten Lund-Johansen

Professor
  • E-mailMorten.Lund-johansen@uib.no
  • Phone+47 55 97 56 66
  • Visitor Address
    Dept. of Neurosurgery, Sentralblokka 8th floor, Haukeland University Hospital
  • Postal Address
    Postboks 7804
    5020 Bergen
Academic article
  • 2020. Gamma Knife Radiosurgery does not alter the copy number aberration profile in sporadic vestibular schwannoma. Journal of Neuro-Oncology. 1-9.
  • 2019. One Hundred Skull Base Meningiomas Operated at Black Lion Specialized Hospital, Addis Ababa, Ethiopia. World Neurosurgery. e1321-e1329.
  • 2019. Long-term effects of conservative management of vestibular schwannoma on dizziness, balance, and caloric function. Otolaryngology and head and neck surgery. 846-851.
  • 2019. Inhibition of mitochondrial respiration prevents BRAF-mutant melanoma brain metastasis. Acta neuropathologica communications. 1-19.
  • 2019. Fatigue in patients with vestibular schwannoma. Acta Neurochirurgica. 1809-1816.
  • 2019. Advances in Vestibular schwannoma microneurosurgery: Improving Results with New Technologies (2019) Editors: L. Mastronardi, T. Fukushima A. Campione 174 pages, illustrated ISBN: 9783030031671 Springer Publishers. Acta Neurochirurgica. 2275.
  • 2019. A prospective study of the natural history of incidental meningioma-Hold your horses! Neuro-Oncology Practice. 438-450.
  • 2018. Thioridazine inhibits autophagy and sensitizes glioblastoma cells to temozolomide. International Journal of Cancer. 1735-1745.
  • 2018. Screening for viral nucleic acids in vestibular schwannoma. Journal of Neurovirology. 730-737.
  • 2018. Rare genetic variation in mitochondrial pathways influences the risk for parkinson's disease. Movement Disorders. 1591-1600.
  • 2018. Quality of life in patients with vestibular schwannomas following gross total or less than gross total microsurgical resection: Should we be taking the entire tumor out? Neurosurgery. 541-547.
  • 2018. Predicting Dural Tear in Compound Depressed Skull Fractures: A Prospective Multicenter Correlational Study. World Neurosurgery. e833-e839.
  • 2018. Patient Motivation and Long-Term Satisfaction with Treatment Choice in Vestibular Schwannoma. World Neurosurgery. e1245-e1252.
  • 2017. Lack of functional normalisation of blood vessels following anti-angiogenic therapy in glioblastoma. Journal of Cerebral Blood Flow and Metabolism. 1741-1753.
  • 2017. Genetic landscape of sporadic vestibular schwannoma. Journal of Neurosurgery. 911-922.
  • 2017. Altered metabolic landscape in IDH‐mutant gliomas affects phospholipid, energy, and oxidative stress pathways. EMBO Molecular Medicine. 1681-1695.
  • 2016. Surgical salvage of recurrent vestibular schwannoma following prior stereotactic radiosurgery. The Laryngoscope. 2580-2586.
  • 2016. Surgical decompression of arachnoid cysts leads to improved quality of life: A prospective study. Neurosurgery. 613-625.
  • 2016. Patient- versus physician-reported facial disability in vestibular schwannoma: an international cross-sectional study. Journal of Neurosurgery. 1015-1024.
  • 2016. Identification of a natural killer cell receptor allele that prolongs survival of cytomegalovirus-positive glioblastoma patients. Cancer Research. 5326-5336.
  • 2016. EGFRvIII mutations can emerge as late and heterogenous events in glioblastoma development and promote angiogenesis through Src activation. Neuro-Oncology. 1644-1655.
  • 2015. What drives quality of life in patients with sporadic vestibular schwannoma? The Laryngoscope. 1697-1702.
  • 2015. The minimal clinically important difference in vestibular schwannoma quality-of-life assessment: An important step beyond P < .05. Otolaryngology and head and neck surgery. 202-208.
  • 2015. Risk factors and analysis of long-term headache in sporadic vestibular schwannoma: a multicenter cross-sectional study. Journal of Neurosurgery. 1276-1286.
  • 2015. Predictors of vertigo in patients with untreated vestibular schwannoma. Otology and Neurotology. 647-652.
  • 2015. Melanoma brain metastasis is independent of lactate dehydrogenase A expression. Neuro-Oncology. 1374-1385.
  • 2015. Long-term quality of life in patients with vestibular schwannoma: an international multicenter cross-sectional study comparing microsurgery, stereotactic radiosurgery, observation, and nontumor controls. Journal of Neurosurgery. 833-842.
  • 2015. Long-term auditory symptoms in patients with sporadic vestibular schwannoma: an international cross-sectional study. Neurosurgery. 218-227.
  • 2015. Glutamine synthetase activity fuels nucleotide biosynthesis and supports growth of glutamine-restricted glioblastoma. Nature Cell Biology. 1556-1568.
  • 2015. Bevacizumab treatment induces metabolic adaptation toward anaerobic metabolism in glioblastomas. Acta Neuropathologica. 115-131.
  • 2014. Multimodal imaging of gliomas in the context of evolving cellular and molecular therapies. Advanced Drug Delivery Reviews. 98-115.
  • 2014. Long-term dizziness handicap in patients with vestibular schwannoma: A multicenter cross-sectional study. Otolaryngology and head and neck surgery. 1028-1037.
  • 2013. Working disability in Norwegian patients with vestibular schwannoma: vertigo predicts future dependence. World Neurosurgery.
  • 2013. Surgery for high-grade gliomas in the aging. Acta Neurologica Scandinavica. 185-193.
  • 2013. Outcome following surgery for intracranial meningiomas in the aging. Acta Neurologica Scandinavica. 161-169.
  • 2013. EGFR wild-type amplification and activation promote invasion and development of glioblastoma independent of angiogenesis. Acta Neuropathologica. 683-698.
  • 2013. Conservative management or gamma knife radiosurgery for vestibular schwannoma: tumor growth, symptoms, and quality of life. Neurosurgery. 48-57.
  • 2013. Automated tracking of nanoparticle-labeled melanoma cells improves the predictive power of a brain metastasis model. Cancer Research. 2445-2456.
  • 2012. Growth of untreated vestibular schwannoma: a prospective study Clinical article. Journal of Neurosurgery. 706-712.
  • 2012. Gamma Knife Treatment of Growing Vestibular Schwannoma in Norway: A Prospective Study. International Journal of Radiation Oncology, Biology, Physics. E161-E166.
  • 2012. Conservative management of vestibular schwannoma-a prospective cohort study: treatment, symptoms, and quality of life. Neurosurgery. 1072-1080.
  • 2011. Six-month preoperative octreotide treatment in unselected, de novo patients with acromegaly: effect on biochemistry, tumour volume, and postoperative cure. Clinical Endocrinology. 736-743.
  • 2011. Meningiomas in children and adolescents: a meta-analysis of individual patient data. The Lancet Oncology. 1229-1239.
  • 2011. Expression of the progenitor marker NG2/CSPG4 predicts poor survival and resistance to ionising radiation in glioblastoma. Acta Neuropathologica. 495-510.
  • 2010. Microarray-based gene expression profiling and DNA copy number variation analysis of temporal fossa arachnoid cysts. Cerebrospinal Fluid Research. 8 pages.
  • 2010. Location, sidedness, and sex distribution of intracranial arachnoid cysts in a population-based sample. Journal of Neurosurgery. 934-939.
  • 2010. Increased NKCC1 expression in arachnoid cysts supports secretory basis for cyst formation. Experimental Neurology. 424-428.
  • 2010. Global Gene Expression Profiling and Tissue Microarray Reveal Novel Candidate Genes and Down-Regulation of the Tumor Suppressor Gene CAV1 in Sporadic Vestibular Schwannomas. Neurosurgery. 998-1019.
  • 2010. Clinical, microbiological and molecular characteristics of six cases of group A streptococcal meningitis in western Norway. Scandinavian Journal of Infectious Diseases. 665-671.
  • 2010. Analysis of vestibular schwannoma size in multiple dimensions: a comparative cohort study of different measurement techniques. Clinical Otolaryngology. 97-103.
  • 2010. Acute visual loss after spinal surgery. Acta Ophthalmologica. 490-492.
  • 2009. Vestibular schwannoma: Surgery or gamma knife radiosurgery? A prospective, nonrandomized study. Neurosurgery. 654-661.
  • 2009. Proteomic profiles differ between bone invasive and noninvasive benign meningiomas of fibrous and meningothelial subtype. Journal of Neuro-Oncology. 321-331.
  • 2009. Gamma knife stereotactic radiosurgery of Nelson syndrome. European Journal of Endocrinology. 143-148.
  • 2008. Preoperative octreotide treatment in newly diagnosed acromegalic patients with macroadenomas increases cure short-term postoperative rates: A prospective, randomized trial. Journal of Clinical Endocrinology and Metabolism. 2984-2990.
  • 2008. Microarray analysis reveals down-regulation of the tumour suppressor gene WWOX and up-regulation of the oncogene TYMS in intracranial sporadic meningiomas. Journal of Neuro-Oncology. 251-259.
  • 2007. Gamma knife stereotactic radiosurgery for acromegaly. European Journal of Endocrinology. 255-263.
  • 2006. Operativ behandling av hormonproduserende hypofyseadenomer (Surgical treatment of hormone-producing pituitary adenomas). Tidsskrift for Den norske legeforening. 1330-1332.
  • 2005. Secretoglobins in the human pituitary: high expression of lipophilin B and its down-regulation in pituitary adenomas. Acta Neuropathologica. 381-386.
  • 2001. Neurosurgical treatment of meningiomas in children and young adults. Child's Nervous System. 719-723.
  • 1999. lacZ transfected glioma cells in syngeneic rats: growth pattern and a characterization of the host immune response against cells transplanted inside and outside the CNS. International Journal of Cancer. 228-235.
  • 1999. Retroviral transfection of the lacZ gene from liz-9 packaging cells to glioma spheroids. International Journal of Developmental Neuroscience. 665-672.
  • 1999. Retroviral transfection of the LacZ gene from Liz 9 packing cells to glioma spheroids. International Journal of Developmental Neuroscience. 665-672.
  • 1999. Laminin expression by glial fibrillary acidic protein positive cells in human gliomas. International Journal of Developmental Neuroscience. 531-539.
  • 1999. Extracellular matrix-induced cell migration from glioblastoma biopsy specimens in vitro. Acta Neuropathologica. 231-239.
  • 1999. Extracellular matrix-induced cell migration from gliobastoma biopsies in vitro. Acta Neuropathologica. 231-39.
  • 1998. Stimulation of extracellular matrix components in the normal brain by invading glioma cells. International Journal of Cancer. 864-872.
  • 1998. Stimulation of extracellular matrix components in the normal brain by invading glioma cells. International Journal of Cancer. 864-872.
  • 1998. Stimulation of extracellular matrix components in the normal brain by invading glioma cells. International Journal of Cancer. 864-872.
  • 1998. Expression of annexin II in glioma cell lines and in brain tumor biopsis. J Neurooncol. 11-18.
  • 1998. Expression of annexin II in glioma cell lines and in brain tumor biopsies. Journal of Neuro-Oncology. 11-18.
  • 1998. Dynamic determination of human glioma invasion in vitro. Journal of Neurosurgery. 441-447.
  • 1998. Dynamic determination of human glioma invasion in vitro. Journal of Neurosurgery. 441-447.
  • 1998. Dynamic determination of human glioma invasion in vitro. Journal of Neurosurgery. 441-447.
  • 1997. Tumor cell invasion and angiogenesis in the central nervous system. Current Opinion in Oncology. 223-229.
  • 1997. Tumor cell invasion and angiogenesis in the central nervous system. Current Opinion in Oncology. 223-229.
  • 1997. Tumor cell invasion and angiogenesis in the central nervous system. Current Opinion in Oncology. 223-229.
  • 1997. Syringomyelia treated with a single non-valved syringoperitoneal shunt. A follow-up study. Neurosurgery. 858-864.
  • 1997. Role of high molecular weight extracellular matrix proteins in glioma cell migration. Neuropathology and Applied Neurobiology. 102-12.
  • 1997. Role of high molecular weight extracellular matrix proteins in glioma cell migration. Neuropathology and Applied Neurobiology. 102-112.
  • 1997. Glioma cell migration on extracellular components. Neuropathology and Applied Neurobiology. 102-112.
  • 1996. Evaluation of cognitive dysfunctions after stereotactic thalamotomy in Parkinson patients. Journal of Neurology, Neurosurgery and Psychiatry. 564-571.
  • 1996. Cognitive function in Parkinson's disease: As compared to normal subjects, and following stereotactic thalamotomy. Journal of Neurology, Neurosurgery and Psychiatry. 564-571.
  • 1994. Subaraknoidalblødning. Alvorlige konsekvenser ved forsinket diagnose. Tidsskrift for Den norske legeforening. 3175-3178.
  • 1994. Shunt failures and complications in adults as related to shunt type, diagnosis, and the experience of the surgeon. Neurosurgery. 839-844.
  • 1994. Leptomeningeal tissue: a barrier against brain tumor cell invasion. Journal of the National Cancer Institute. 1593-1599.
  • 1994. Leptomeningeal tissue, a barrier against brain tumor cell invasion. Journal of the National Cancer Institute. 1593-1599.
  • 1992. Effects of growth factors on a human glioma cell line during invasion into rat brain aggregates in culture. Acta Neuropathologica. 190-197.
  • 1992. Effects of growth factors on a human glioma cell line during growth and invasion. Acta Neuropathologica. 2-2.
  • 1992. Effect of growth factors on a human glioma cell line during invasion into rat brain aggregates in culture. Acta Neuropathologica. 190-197.
  • 1991. The IgG FcRII and the PI-linked IgG Fc3 trigger cytoplasmic calcium fluxes independently in human granulocytes. Scandinavian Journal of Immunology. 261-266.
  • 1991. Deletionmutant epidermal growth factor reception in human gliomas: Effect of type 2 mutation on receptor function. Biochemical and Biophysical Research Communications - BBRC. 1413-1420.
  • 1991. A metalloproteinase, capable of destroying cultured brain tissue isolated from rat glioma cells. Anticancer Research. 1001-1006.
  • 1989. Multicellular Tumor Spheroids in Serum-Free Culture. Anticancer Research. 413-420.
Editorial
  • 2017. Awake craniotomy for vestibular schwannoma. Acta Neurochirurgica. 1587-1588.
  • 2013. Expect the Unexpected: Incidental Findings on Brain Magnetic Resonance Imaging. World Neurosurgery. E119-E120.
  • 2012. Vestibular schwannomas Response. Journal of Neurosurgery. 704-705.
  • 2011. Decompressive Craniectomy for Traumatic Brain Injury-When and How? World Neurosurgery. 454-455.
Reader opinion piece
  • 2014. In reply. Neurosurgery.
Book review
  • 2016. Referee Report For: Open discectomy vs microdiscectomy for lumbar disc herniation – a protocol for a pragmatic comparative effectiveness study. F1000 Research. 2170.
Academic anthology/Conference proceedings
  • 2005. Cell encapsulation therapy for malignant gliomas. Springer.
Feature article
  • 2017. An Ethiopian training program in neurosurgery with Norwegian support. World Neurosurgery. 2-5.
Letter to the editor
  • 2018. No evidence for rare TRAP1 mutations influencing the risk of idiopathic Parkinson's disease. Brain. e16-e16.
Doctoral dissertation
  • 2019. Long-term Quality of Life and symptoms in patients with vestibular schwannoma.
  • 1991. Invasive glioma cells in tissue culture. A study of serum-free culture methods and invasion-related mechanisms. Thesis. (dr.med.).
Academic chapter/article/Conference paper
  • 1998. Brain tumor cell invasion: Anatomical considerations. 13 pages.
  • 1992. Tumor spheroids from monolayer cultures. 16 pages.
  • 1992. Tumor spheroids from monolayer cultures. 16 pages.
  • 1991. Tumor spheroids from monolayer cultures. 16 pages.
Abstract
  • 2013. EGFR wild-type amplification and activation promote invasion and development of glioblastoma independent of angiogenesis. Neuro-Oncology. 6-6.
  • 2013. BRAIN-SPECIFIC GENE SIGNATURE OF MELANOMA METASTASIS. Neuro-Oncology. 27-27.
  • 2013. ACTIVATION OF THE PROTOTYPICAL SFK c-Src PROMOTES ANGIOGENESIS OF HUMAN GLIOBLASTOMA. Neuro-Oncology. 3-3.
  • 2012. GROSS TOTAL RESECTION IS THE THERAPEUTIC GOAL FOR CHILDHOOD AND ADOLESCENT MENINGIOMA: AN INDIVIDUAL PATIENT META-ANALYSIS. Neuro-Oncology. 119-119.
  • 2010. Does gamma knife radiosurgery stop vestibular schwannoma growth? A prospective study. European Journal of Medical Research. 143-144.
Poster
  • 2014. Surgery for high grade gliomas in the aging.
  • 2014. Outcome following surgery for intracranial meningiomas in the aging.
Academic literature review
  • 2016. EANO guidelines for the diagnosis and treatment of meningiomas. e383-e391.
  • 2011. Gene expression profiling of meningiomas: current status after a decade of microarray-based transcriptomic studies. 447-456.
  • 2007. Treatment of vestibular schwannomas. Why, when and how? 647-660.

More information in national current research information system (CRIStin)